These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16481709)

  • 41. Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Farajzadeh S; Rahnama Z; Fathabadi EA; Heshmatkhah A
    Int J Dermatol; 2012 Oct; 51(10):1221-5. PubMed ID: 22994669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A family cluster of cutaneous Leishmania major infection unresponsive to intralesional meglumine antimonial: Case reports.
    Ziaee M; Ghatee MA; Taylor WR; Karamian M
    Indian J Med Microbiol; 2022; 40(3):451-454. PubMed ID: 35680474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutaneous lupoid leishmaniasis: a case report.
    Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
    Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Childhood cutaneous leishmaniasis: report of 117 cases from Iran.
    Talari SA; Talaei R; Shajari G; Vakili Z; Taghaviardakani A
    Korean J Parasitol; 2006 Dec; 44(4):355-60. PubMed ID: 17170577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia.
    Mlika RB; Hamida MB; Hammami H; Jannet SB; Badri T; Fenniche S; Mokhtar I
    Dermatol Ther; 2012; 25(6):615-8. PubMed ID: 23210761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
    Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind randomized clinical trial of a topical herbal extract (Z-he) vs. systemic meglumine antimonate.
    Momeni AZ; Aminjavaheri M
    Int J Dermatol; 2000 Nov; 39(11):880. PubMed ID: 11123462
    [No Abstract]   [Full Text] [Related]  

  • 48. Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis.
    Noguera-Morel L; Azorin D; Xirotagaros G
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sporotrichoid cutaneous leishmaniasis].
    López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S
    Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940
    [No Abstract]   [Full Text] [Related]  

  • 50. Unusual clinical variants of cutaneous leishmaniasis in Pakistan.
    Raja KM; Khan AA; Hameed A; Rahman SB
    Br J Dermatol; 1998 Jul; 139(1):111-3. PubMed ID: 9764160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Zosteriform cutaneous leishmaniasis due to Leishmania ( Viannia ) panamensis and Leishmania ( Viannia ) braziliensis: report of three cases.
    Morales CA; Palacio J; Rodríguez G; Camargo YC
    Biomedica; 2014; 34(3):340-4. PubMed ID: 25504121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unusual form of cutaneous leishmaniasis: erysipeloid form.
    Mnejja M; Hammami B; Chakroun A; Achour I; Charfeddine I; Chakroun A; Turki H; Ghorbel A
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Apr; 128(2):95-7. PubMed ID: 21251895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leishmaniasis of the Feet Sole: A Case Report.
    Ayatollahi J; Bafghi AF; Shahcheraghi SH
    Turkiye Parazitol Derg; 2017 Mar; 41(1):48-49. PubMed ID: 28483734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cutaneous leishmaniasis: an overview.
    Hepburn NC
    J Postgrad Med; 2003; 49(1):50-4. PubMed ID: 12865571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pediatric Dermatology Photoquiz: Refractory Purulent Paronychia in a Young Girl. Paronychial cutaneous leishmaniasis.
    Oguz Topal I; Duman H; Baz V; Gungor S; Kocaturk E; Özekinci S
    Pediatr Dermatol; 2016; 33(1):93-4. PubMed ID: 26758096
    [No Abstract]   [Full Text] [Related]  

  • 56. Localization of varicella around cutaneous leishmaniasis.
    Siadat AH; Nilforoush Zadeh MA; Moradi SH; Baradaran EH
    Indian J Dermatol Venereol Leprol; 2007; 73(2):124-6. PubMed ID: 17456925
    [No Abstract]   [Full Text] [Related]  

  • 57. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
    Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disseminated cutaneous leishmaniasis: ulcerovegetative and ulcero-crusted lesions.
    Sgarbi IM; Santos FD; Monteiro VE; Fonseca SN; Bernardes Filho F
    Braz J Infect Dis; 2017; 21(2):201-202. PubMed ID: 28012931
    [No Abstract]   [Full Text] [Related]  

  • 59. Nonhealing ulcers: an infectious viewpoint.
    Shahlaee A; Jazayeri SB
    Mayo Clin Proc; 2014 Jan; 89(1):e5-6. PubMed ID: 24388036
    [No Abstract]   [Full Text] [Related]  

  • 60. Cutaneous Leishmaniasis with HIV.
    Talat H; Attarwala S; Saleem M
    J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S93-5. PubMed ID: 24906285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.